LGND — Ligand Pharmaceuticals Incorporated Share News
0.000.00%
Last trade - 00:00- $5.95bn
- $5.72bn
- $215.02m
Ligand Pharmaceuticals Q4 revenue rises 39% on royalty growth
Ligand Pharma Q3 revenue jumps; raises 2025 guidance
Brief: Arecor Therapeutics Announces Royalty Financing Agreement With Ligand To Raise Up To $11 Mln
Brief: Ligand Pharmaceuticals Entered Third Amendment To Credit Agreement - SEC Filing
OmniAb drops after $30 mln equity financing
U.S. STOCKS ON THE MOVE- Alphabet, Starbucks, Resideo Technologies
U.S. STOCKS ON THE MOVE-Starbucks, Resideo Technologies, Mercury Systems
Ligand rises after offering $400 million convertible bonds
Brief: Ligand Prices $400 Million Convertible Senior Notes Offering
Ligand Pharmaceuticals falls on planned $400 million convertible bonds offering
Ligand Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Orchestra BioMed drops after $40 mln equity raise
Brief: Pelthos Therapeutics Completes Merger With Channel Therapeutics
Brief: Ligand Announces Completion Of Pelthos Therapeutics Merger With Channel Therapeutics
Ligand Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Ligand Subsidiary Pelthos Therapeutics To Combine With Channel Therapeutics
U.S. STOCKS ON THE MOVE-JPMorgan Chase, Capri, Novavax
U.S. STOCKS ON THE MOVE-AppLovin, Ligand Pharma, Dexcom
Stifel starts coverage on Ligand Pharma with 'buy'